Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research led by the University of Oxford has revealed how the complex cultural and social environment in developing countries can complicate the use of new diagnostic technologies to fight the global superbug crisis.

Image courtesy of Shutterstock

The research, led by Dr Marco J Haenssgen at the CABDyN Complexity Centre and the Centre for Tropical Medicine and Global Health,  involved a new finger-prick blood test (C-reactive protein) to help nurses and doctors decide whether their patients need antibiotic treatment.

The superbug crisis has arisen because microbes are becoming increasingly resistant to antibiotics and other antimicrobials. The severity of the problem has been described in a recent World Bank report entitled 'Drug-Resistant Infections: A Threat to Our Economic Future', which warns that the current trends of antimicrobial use can entail 'a reversal of the public-health gains of the past century, and the economic growth, development, and poverty reduction these gains enabled.'

Find out more (University of Oxford website)

Similar stories

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from Department of Physiology, Anatomy & Genetics (DPAG), in collaboration with NHS Blood and Transplant, has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.